Effect of magnesium sulphate, NMDA antagonist, to tourniquet pain.

Effect of magnesium sulphate, NMDA antagonist, to tourniquet pain. - Magnesium sulphate and tourniquet pain.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004632

Enrollment

Registered

2010-12-01

Start date

2007-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volunteer

Interventions

Control group(normal saline) M1 group (magnesium, 1 g) M2 group (magnesium, 2 g) M4 group (magnesium, 4 g)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy volunteers. ASA physical status class I.

Exclusion criteria

Exclusion criteria: Hypertension, ischemic heart disease, deep vein thrombosis, and a past history of chronic pain, mental disorder, or substance misuse.

Design outcomes

Primary

Measure	Time frame
VAS pain scale	—

Secondary

Measure	Time frame
Blood pressure and heart rate	—

Countries

Japan

Contacts

Public ContactTsuyoshi Satsumae

University of Tsukuba Department of Anesthesiology and Critical Care Medicine

029-853-3092

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026